135 related articles for article (PubMed ID: 37792102)
1. Effects of a calorie-restricted dietary intervention on weight loss and gut microbiota diversity in obese patients with sleep deprivation.
Wen S; Ni Y; Dai Y; Liu Z; Wang X; Zhang J; Yu W; Hu W
Eat Weight Disord; 2023 Oct; 28(1):80. PubMed ID: 37792102
[TBL] [Abstract][Full Text] [Related]
2. Effects of different weight loss dietary interventions on body mass index and glucose and lipid metabolism in obese patients.
Ma Y; Sun L; Mu Z
Medicine (Baltimore); 2023 Mar; 102(13):e33254. PubMed ID: 37000111
[TBL] [Abstract][Full Text] [Related]
3. Calorie restriction improves metabolic state independently of gut microbiome composition: a randomized dietary intervention trial.
Sowah SA; Milanese A; Schübel R; Wirbel J; Kartal E; Johnson TS; Hirche F; Grafetstätter M; Nonnenmacher T; Kirsten R; López-Nogueroles M; Lahoz A; Schwarz KV; Okun JG; Ulrich CM; Nattenmüller J; von Eckardstein A; Müller D; Stangl GI; Kaaks R; Kühn T; Zeller G
Genome Med; 2022 Mar; 14(1):30. PubMed ID: 35287713
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the Gut Microbial Community of Obese Patients Following a Weight-Loss Intervention Using Whole Metagenome Shotgun Sequencing.
Louis S; Tappu RM; Damms-Machado A; Huson DH; Bischoff SC
PLoS One; 2016; 11(2):e0149564. PubMed ID: 26919743
[TBL] [Abstract][Full Text] [Related]
5. Effects of a Dulaglutide plus Calorie-Restricted Diet versus a Calorie-Restricted Diet on Visceral Fat and Metabolic Profiles in Women with Polycystic Ovary Syndrome: A Randomized Controlled Trial.
Zhang Y; Qu Z; Lu T; Shao X; Cai M; Dilimulati D; Gao X; Mao W; Hu F; Su L; Liao Q; Han T; Zhang M; Qu S
Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771262
[TBL] [Abstract][Full Text] [Related]
6. Different mechanisms in weight loss-induced blood pressure reduction between a calorie-restricted diet and exercise.
Masuo K; Rakugi H; Ogihara T; Lambert GW
Hypertens Res; 2012 Jan; 35(1):41-7. PubMed ID: 21814218
[TBL] [Abstract][Full Text] [Related]
7. Effects of three medical nutrition therapies on nutritional metabolism and intestinal flora in overweight/obese with polycystic ovary syndrome (PCOS): Study protocol for a randomised controlled trial.
Dou P; Zhuang ZH; Zhao YM; Yang YX; Zhang TT; Xu Y; Xue Q; Huang T
Asia Pac J Clin Nutr; 2023; 32(1):33-39. PubMed ID: 36997483
[TBL] [Abstract][Full Text] [Related]
8. The Gut Microbiota during a Behavioral Weight Loss Intervention.
Stanislawski MA; Frank DN; Borengasser SJ; Ostendorf DM; Ir D; Jambal P; Bing K; Wayland L; Siebert JC; Bessesen DH; MacLean PS; Melanson EL; Catenacci VA
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579125
[TBL] [Abstract][Full Text] [Related]
9. [Effects of three medical nutrition therapies for weight loss on metabolic parameters and androgen level in overweight/obese patients with polycystic ovary syndrome].
Dou P; Zhang TT; Xu Y; Xue Q; Shang J; Yang XL
Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(14):1035-1041. PubMed ID: 37032153
[No Abstract] [Full Text] [Related]
10. Six-Week Exercise Training With Dietary Restriction Improves Central Hemodynamics Associated With Altered Gut Microbiota in Adolescents With Obesity.
Huang J; Liao J; Fang Y; Deng H; Yin H; Shen B; Hu M
Front Endocrinol (Lausanne); 2020; 11():569085. PubMed ID: 33365012
[TBL] [Abstract][Full Text] [Related]
11. Effects of Synbiotic Supplement on Human Gut Microbiota, Body Composition and Weight Loss in Obesity.
Sergeev IN; Aljutaily T; Walton G; Huarte E
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31952249
[TBL] [Abstract][Full Text] [Related]
12. Fecal microbiota and bile acid interactions with systemic and adipose tissue metabolism in diet-induced weight loss of obese postmenopausal women.
Alemán JO; Bokulich NA; Swann JR; Walker JM; De Rosa JC; Battaglia T; Costabile A; Pechlivanis A; Liang Y; Breslow JL; Blaser MJ; Holt PR
J Transl Med; 2018 Sep; 16(1):244. PubMed ID: 30176893
[TBL] [Abstract][Full Text] [Related]
13. Effects of gut microbiota and fatty acid metabolism on dyslipidemia following weight-loss diets in women: Results from a randomized controlled trial.
Ma Y; Sun Y; Sun L; Liu X; Zeng R; Lin X; Li Y
Clin Nutr; 2021 Nov; 40(11):5511-5520. PubMed ID: 34656033
[TBL] [Abstract][Full Text] [Related]
14. Decreased basal levels of glucagon-like peptide-1 after weight loss in obese subjects.
de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O
Ann Nutr Metab; 2007; 51(2):134-8. PubMed ID: 17536190
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiota Serves a Predictable Outcome of Short-Term Low-Carbohydrate Diet (LCD) Intervention for Patients with Obesity.
Zhang S; Wu P; Tian Y; Liu B; Huang L; Liu Z; Lin N; Xu N; Ruan Y; Zhang Z; Wang M; Cui Z; Zhou H; Xie L; Chen H; Sun J
Microbiol Spectr; 2021 Oct; 9(2):e0022321. PubMed ID: 34523948
[TBL] [Abstract][Full Text] [Related]
16. Changes of gut microbiota between different weight reduction programs.
Lin BY; Lin WD; Huang CK; Hsin MC; Lin WY; Pryor AD
Surg Obes Relat Dis; 2019 May; 15(5):749-758. PubMed ID: 30935838
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota and glucometabolic alterations in response to recurrent partial sleep deprivation in normal-weight young individuals.
Benedict C; Vogel H; Jonas W; Woting A; Blaut M; Schürmann A; Cedernaes J
Mol Metab; 2016 Dec; 5(12):1175-1186. PubMed ID: 27900260
[TBL] [Abstract][Full Text] [Related]
18. Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance.
Tzotzas T; Papadopoulou FG; Tziomalos K; Karras S; Gastaris K; Perros P; Krassas GE
J Clin Endocrinol Metab; 2010 Sep; 95(9):4251-7. PubMed ID: 20534751
[TBL] [Abstract][Full Text] [Related]
19. Long-term dietary intervention reveals resilience of the gut microbiota despite changes in diet and weight.
Fragiadakis GK; Wastyk HC; Robinson JL; Sonnenburg ED; Sonnenburg JL; Gardner CD
Am J Clin Nutr; 2020 Jun; 111(6):1127-1136. PubMed ID: 32186326
[TBL] [Abstract][Full Text] [Related]
20. Changes in Gut Microbiota-Related Metabolites and Long-term Successful Weight Loss in Response to Weight-Loss Diets: The POUNDS Lost Trial.
Heianza Y; Sun D; Smith SR; Bray GA; Sacks FM; Qi L
Diabetes Care; 2018 Mar; 41(3):413-419. PubMed ID: 29305401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
